The SFC-backed vaccine developer has wrapped up its series B-2 round after holding an initial close in early 2019.

Sage has agreed a partnership with the business management software developer which will involve it leading a $33.5m round.

Tencent led a series A2 round for the cell analysis technology developer that included Lilly Asia Ventures and Softbank China Venture Capital.

Nio Capital led the Tencent and Bertelsmann Asia Investments-backed home fitness technology developer's series A-plus round.

OSI has reinvested in the Oxford fusion energy spinout now set to expand its R&D capacity and headcount.

SIG Asia-backed pet lifestyle goods provider has secured funding in a round led by ClearVue Partners with the aim of driving international expansion.

The hydrogen energy provider has raised $34.3m, more than two thirds coming in the form of convertible debt financing from AP Moller Holdings.

Existing investor General Motors led a round that will support the car maintenance and refueling provider's expansion and recruitment.

Neurodegenerative disease management platform Octave Bioscience has now raised more than $48m in total, Blue Venture Fund and Echo Health Ventures backing its latest round.

Biopharmaceutical company Origenis helped form the neurological and immunological disease drug developer, which has revealed series A and B funding.